The metabolic and mitogenic properties of basal insulin analogues

por Tennagels, Norbert, Werner, Ulrich
Publicado 2013

On ceramides, other sphingolipids and impaired glucose homeostasis()

por Larsen, Philip J., Tennagels, Norbert
Publicado 2014

Equipotency of insulin glargine 300 and 100 U/mL with intravenous dosing but differential bioavailability with subcutaneous dosing in dogs

por Werner, Ulrich, Tennagels, Norbert, Fanelli, Carmine G., Bolli, Geremia B.
Publicado 2020

Metabolic effect and receptor signalling profile of a non-metabolisable insulin glargine analogue

por Werner, Ulrich, Korn, Marcus, Schmidt, Ronald, Wendrich, Thomas M., Tennagels, Norbert
Publicado 2014

In Vitro Metabolic and Mitogenic Signaling of Insulin Glargine and Its Metabolites

por Sommerfeld, Mark R., Müller, Günter, Tschank, Georg, Seipke, Gerhard, Habermann, Paul, Kurrle, Roland, Tennagels, Norbert
Publicado 2010

Concentrations of Insulin Glargine and Its Metabolites During Long-Term Insulin Therapy in Type 2 Diabetic Patients and Comparison of Effects of Insulin Glargine, Its Metabolites,...

por Varewijck, Aimee J., Yki-Järvinen, Hannele, Schmidt, Ronald, Tennagels, Norbert, Janssen, Joseph A.M.J.L.
Publicado 2013

Facile folding of insulin variants bearing a prosthetic C-peptide prepared by α-ketoacid-hydroxylamine (KAHA) ligation

por Boross, Gábor N., Shimura, Satomi, Besenius, Melissa, Tennagels, Norbert, Rossen, Kai, Wagner, Michael, Bode, Jeffrey W.
Publicado 2018

Effect of the long-acting insulin analogues glargine and degludec on cardiomyocyte cell signalling and function

por Hartmann, Thorsten, Overhagen, Sabrina, Ouwens, D. Margriet, Raschke, Silja, Wohlfart, Paulus, Tennagels, Norbert, Wronkowitz, Nina, Eckel, Jürgen
Publicado 2016

Effect of Insulin Analogues on Insulin/IGF1 Hybrid Receptors: Increased Activation by Glargine but Not by Its Metabolites M1 and M2

por Pierre-Eugene, Cécile, Pagesy, Patrick, Nguyen, Tuyet Thu, Neuillé, Marion, Tschank, Georg, Tennagels, Norbert, Hampe, Cornelia, Issad, Tarik
Publicado 2012

The role of C16:0 ceramide in the development of obesity and type 2 diabetes: CerS6 inhibition as a novel therapeutic approach

por Raichur, Suryaprakash, Brunner, Bodo, Bielohuby, Maximilian, Hansen, Gitte, Pfenninger, Anja, Wang, Bing, Bruning, Jens C., Larsen, Philip Just, Tennagels, Norbert
Publicado 2019

Insulin Receptor Phosphorylation by Endogenous Insulin or the Insulin Analog AspB10 Promotes Mammary Tumor Growth Independent of the IGF-I Receptor

por Gallagher, Emily Jane, Alikhani, Nyosha, Tobin-Hess, Aviva, Blank, Jeffrey, Buffin, Nicholas J., Zelenko, Zara, Tennagels, Norbert, Werner, Ulrich, LeRoith, Derek
Publicado 2013

Evaluation of the innate immunostimulatory potential of originator and non-originator copies of insulin glargine in an in vitro human immune model

por Luna, Ernesto, Agrawal, Pankaj, Mehta, Riyaz, Boone, Maria E., Vernhes, Charlotte, Denys, Colombe, Small, Robert, Mukherjee, Bhaswati, Tennagels, Norbert, Maerten, Stefan, Drake, Donald R.
Publicado 2018

Insulin Fused to Apolipoprotein A-I Reduces Body Weight and Steatosis in DB/DB Mice

por Ardaiz, Nuria, Gomar, Celia, Vasquez, Marcos, Tenesaca, Shirley, Fernandez-Sendin, Myriam, Di Trani, Claudia Augusta, Belsué, Virginia, Escalada, Javier, Werner, Ulrich, Tennagels, Norbert, Berraondo, Pedro
Publicado 2021

Liver-Specific Knockdown of Class IIa HDACs Has Limited Efficacy on Glucose Metabolism but Entails Severe Organ Side Effects in Mice

por Ziegler, Nicole, Raichur, Suryaprakash, Brunner, Bodo, Hemmann, Ulrike, Stolte, Manuela, Schwahn, Uwe, Prochnow, Hans-Peter, Metz-Weidmann, Christiane, Tennagels, Norbert, Margerie, Daniel, Wohlfart, Paulus, Bielohuby, Maximilian
Publicado 2020

The signalling conformation of the insulin receptor ectodomain

por Weis, Felix, Menting, John G., Margetts, Mai B., Chan, Shu Jin, Xu, Yibin, Tennagels, Norbert, Wohlfart, Paulus, Langer, Thomas, Müller, Christoph W., Dreyer, Matthias K., Lawrence, Michael C.
Publicado 2018

Molecular basis for inhibiting human glucose transporters by exofacial inhibitors

por Wang, Nan, Zhang, Shuo, Yuan, Yafei, Xu, Hanwen, Defossa, Elisabeth, Matter, Hans, Besenius, Melissa, Derdau, Volker, Dreyer, Matthias, Halland, Nis, He, Kaihui Hu, Petry, Stefan, Podeschwa, Michael, Tennagels, Norbert, Jiang, Xin, Yan, Nieng
Publicado 2022